• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 36
  • 12
  • 11
  • 6
  • 2
  • 2
  • 2
  • 1
  • Tagged with
  • 91
  • 91
  • 26
  • 18
  • 16
  • 12
  • 12
  • 11
  • 11
  • 11
  • 8
  • 8
  • 7
  • 7
  • 7
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
71

Novel Mechanisms of Immune Regulation by NF-kappaB c-Rel

de Jesus, Tristan J. January 2019 (has links)
No description available.
72

Loss of SIMPL increases TNFα sensitivity during hematopoiesis

Benson, Eric Ashley 18 March 2009 (has links)
Indiana University-Purdue University Indianapolis (IUPUI) / The innate and adaptive immune responses are critical for host survival. The TNFα/NF-κB signaling pathway is a major regulator of the immune response. The TNFα/NF-κB signaling pathway has also been proposed to play a role in the regulation of hematopoiesis. In the TNFα signaling pathway, full induction of NF-κB (specifically the p65 subunit) dependent transcription is regulated by a co-activator SIMPL. The biological significance of SIMPL in TNFα dependent responses is poorly understood. To study SIMPL in vitro and in vivo in mammalian cells, a knockdown system utilizing shRNA (short hairpin RNA) was used. Analysis of hematopoietic progenitor cells infected with a retrovirus encoding the SIMPL shRNA was used to study the role of SIMPL in hematopoiesis. The ability of progenitor cells lacking SIMPL to grow and differentiate was not compromised. In contrast in the progenitors cells lacking SIMPL, TNFα mediated inhibition of colony formation was significantly enhanced. These growth inhibitory effects of SIMPL were not due to an increase in apoptosis. The enhanced inhibitory affects were specific for TNFα and not found in other common hematopoietic inhibitors (TGF-β1 and IFNγ). Results of this work reveal that SIMPL is a component of the hematopoiesis that is required for TNFα dependent effects upon myeloid progenitors.
73

Targeting Cancer Stem-LIike Cells in Human Esophageal Squamous Carcinoma Cell Lines by Curcumin

Almanaa, Taghreed N. 16 December 2013 (has links)
No description available.
74

Reactive Oxygen Modulates B Lymphocyte Function via the NFκB/Rel Pathway

Romer, Eric J. 30 October 2013 (has links)
No description available.
75

Cell-Type Specific Actions of Inflammatory Mediators in the CNS

An, Ying 08 August 2016 (has links)
No description available.
76

Alternative NF-κB Regulation of Skeletal Muscle Oxidative Metabolism

Shintaku, Jonathan Kenji 28 December 2016 (has links)
No description available.
77

TLR8 and Nuclear GSK3ß are Novel Therapeutic Targets in AML

Ignatz-Hoover, James J. 08 February 2017 (has links)
No description available.
78

Rôles des kinases IKK et IKK-related dans les maladies inflammatoires chroniques : implications dans l’athérosclérose et la réponse hypoxique

Gravel, Simon-Pierre 12 1900 (has links)
L’inflammation est un procédé complexe qui vise l’élimination de l’agent causal de dommages tissulaires en vue de faciliter la réparation du tissu affecté. La persistance de l’agent causal ou l’incapacité à résoudre l’inflammation mène à un dérèglement homéostatique chronique qui peut avoir une incidence sur la morbidité et la mortalité. L’athérosclérose est une condition inflammatoire chronique des vaisseaux sanguins dont l’origine est multifactorielle. L’hypertension et l’état infectieux représentent respectivement des facteurs de risque classiques et émergents du développement de cette maladie. Les fondements initiaux de l’inflammation font intervenir l’immunité innée, la première ligne de défense dont disposent les cellules pour répondre à un signal de danger. Le but de cette thèse est d’examiner le rôle pro-inflammatoire d’une famille de kinases essentielles à l’immunité innée, soit celle des kinases de IkappaB (IKK) et des kinases IKK-related. Les kinases IKKalpha et IKKbeta forment le complexe IKK avec la molécule adaptatrice NEMO/IKKgamma. Ce complexe est chargé d’effectuer la phosphorylation de l’inhibiteur de NF-kappaB, IkappaBalpha, ce qui mène à sa dégradation et à la libération du facteur de transcription NF-kappaB. Nous montrons que le peptide vasoactif angiotensine II (AngII) induit l’activité phosphotransférase d’IKKbeta dans les VSMC par immunoprécipitation de NEMO puis essai kinase in vitro. Grâce à une approche ARN interférence (ARNi) dirigée contre IKK, nous montrons que cette kinase est responsable de la phosphorylation de p65/RelA. Nous montrons que le mécanisme d’induction de NF-kappaB par l’AngII est atypique, puisqu’il ne module pas IkappaBalpha, et montrons à l’aide d’inhibiteurs pharmacologiques que l’activation de p65 est indépendante des voies MEK-ERK-RSK, PI3K et de la transactivation du récepteur de l’EGF. Les kinases IKK-related Tank-binding kinase 1 (TBK1) et IKK-i sont quant à elles principalement activées suite à une infection bactérienne ou virale. Ces kinases phosphorylent directement le facteur de transcription interferon regulatory factor (IRF)-3. Nous montrons que le cytomégalovirus humain, un pathogène associé à l’athérosclérose, a la capacité d’induire l’activation de TBK1 dans les VSMC. L’usage d’ARNi dirigé contre TBK1 et IKKi montre que les 2 kinases sont impliquées dans l’activation d’IRF-3. De plus, nous montrons à l’aide d’une lignée de VSMC exprimant une version dominante négative d’IRF-3 que ce dernier est essentiel à la synthèse des chimiokines RANTES et IP-10, tel qu’analysé par RT-PCR. Par ailleurs, il a récemment été montré que les kinases IKK-related étaient étroitement liées à la transformation oncogénique, et que TBK1 était pro-angiogénique. Or, l’angiogenèse est le plus souvent modulée par la réponse hypoxique qui est d’ailleurs commune à la majorité des processus inflammatoires. Le facteur de transcription hypoxia inducible factor (HIF)-1 module l’angiogenèse, l’inflammation et la survie cellulaire. Nous montrons à l’aide de cellules Tbk1 et Ikbke -/- et d’une approche lentivirale que TBK1 est spécifiquement impliquée dans l’induction traductionnelle de HIF-1alpha en condition de stress hypoxique. L’expression de TBK1 est induite sous ces conditions, et cette kinase module la phosphorylation de ERK, RSK, Akt et TSC1. Les résultats originaux présentés dans cette thèse montrent donc que les kinases IKK et IKK-related exercent leurs actions pro-inflammatoires par des mécanismes distincts. / Inflammation is a complex process that allows elimination of tissular damaging agents and thus facilitates wound repair. Persistance of a damaging agent or the incapacity to resolve the inflammatory state leads to chronic homeostatic deregulation with putative incidence on morbidity and mortality. Atherosclerosis is an inflammatory state of blood vessels which origins are multifactorial. Hypertension and the infectious state represent classical and emerging factors of atherosclerosis development, respectively. The innate immune response takes place in the initial steps of inflammation, and represents the first cellular line of defense against danger signals. The goal of this thesis is to examine the pro-inflammatory roles of the IkB kinases (IKK) and the IKK-related kinases, which are essential innate immune response protein kinases. IKKalpha and IKKbeta form, together with NEMO/IKKgamma, the IKK complex. This complex is responsible of the phosphorylation of the inhibitor of NF-kappaB, IkappaBalpha, a process that leads to its degradation and NF-kappaB release. By immunoprecipitation of NEMO and assessment of the IKK complex activity in vitro, we show that the vasoactive peptide angiotensin II (AngII) induces IKKbeta phosphotransferase activity in vascular smooth muscle cells (VSMC). The use of RNA interference (RNAi) against IKKbeta reveals that this kinase is responsible for p65/RelA phosphorylation. AngII modulation of NF-kappaB is atypical since it does not modulate IkappaB. Moreover, the use of pharmacological inhibitors shows that p65 induction is independent of both MEK-ERK-RSK and PI3K pathways, and that it does not involve EGF receptor transactivation. IKK-related kinases Tank-binding kinase 1 (TBK1) and IKK-i are known to be induced by bacterial and viral infections. These kinases are able to phosphorylate directly interferon regulatory factor (IRF)-3 transcription factor. Human cytomegalovirus (HCMV) seropositivity was shown to be linked to atherosclerosis development. We show that TBK1 activity is induced in HCMV-infected VSMC. RNAi directed against TBK1 and IKK-i reveals that both kinases are required for IRF-3 activation. The use of a VSMC line that express a dominant negative version if IRF-3 shows that this transcription factor is involved in the induction of RANTES and IP-10 chemokines, as assessed by RT-PCR. In addition, IKK-related kinases were recently shown to be implicated in oncogenic transformation. TBK1 was also shown to be pro-angiogenic. Angiogenesis is known to be regulated by the hypoxic response, a common condition of inflammatory processes. Hypoxia-inducible factor (HIF)-1 is a transcription factor that modulates angiogenesis, inflammation and cell survival. We show with the use of Tbk1 and Ikbke -/- cells combined with the use of a lentiviral approach that TBK1 is specifically involved in HIF-1alpha translational induction under hypoxic stress. We also show that TBK1 expression is enhanced under theses conditions, and that this kinase modulates the phosphorylation of ERK, RSK, Akt and TSC1. In conclusion, the results presented in this thesis show that the IKK and IKK-related kinases are both pro-inflammatory, and exert their actions by distinct mechanisms.
79

Dissection du rôle fondamental de l'hyperglycémie sur la morphogenèse rénale

Tran, Stella Lê Minh January 2008 (has links)
Mémoire numérisé par la Division de la gestion de documents et des archives de l'Université de Montréal.
80

Mutated in colorectal cancer (MCC): a putative tumour suppressor gene in colorectal cancer

Sigglekow, Nicholas David, Garvan Institute of Medical Research, Faculty of Medicine, UNSW January 2009 (has links)
Colorectal cancer (CRC) remains a significant burden in contemporary society due to an aging population, unhealthy dietary choices and an increasingly sedentary lifestyle. While the underlying defects for many hereditary forms of CRC have been determined, many genetic and epigenetic changes promoting common sporadic CRCs have yet to be identified. The Mutated in Colorectal Cancer (MCC) gene, identified in 1991, was initially thought to be responsible for the hereditary form of CRC, familial adenomatous polyposis, before the discovery of the susceptibility gene Adenomatous Polyposis Coli (APC), which then became the focus of intense research. Recent data, however, suggests that MCC may also be important in the development of CRC. I have investigated the mechanism of MCC gene silencing, the putative structure, and multiple functions of MCC. MCC was frequently silenced by promoter hypermethylation in CRC cell lines and primary tumours. MCC methylation showed strong molecular and clinicopathological associations with hallmarks of the serrated neoplasia pathway. Furthermore, MCC methylation was more frequent in serrated precursor lesions compared with adenomas, thus occurring early during carcinogenesis. MCC is highly conserved in complex multicellular organisms. Re-introduction of MCC in CRC cell lines resulted in partial G1 to S phase, and G2/M phase cell cycle blocks, potentially by upregulating cell cycle inhibitor gene transcription and interfering with the process of mitotic checkpoints and division, respectively. Changes in MCC levels also modulated NF?B pathway signalling, the pathway required for maintaining cell viability and proliferation in colonic epithelial cells. In particular, MCC overexpression suppressed both TNF? and LPS-induced NF?B activation, decreasing both the magnitude and rate of cellular responses. Overexpression also resulted in downregulation of proteins involved in canonical NF?B pathway signalling, while increasing the transcription of non-canonical NF?B genes. Therefore, MCC may direct activation of this pathway to a specific subset of NF?B-regulated genes. These data provide a molecular basis for the role of MCC as a tumour suppressor gene in CRC. MCC may have multiple functions, regulating cell cycle progression and modulating NF?B pathway signalling, either through direct involvement in pathway signalling cascades, or by providing a scaffold on which signalling events can occur.

Page generated in 0.0823 seconds